Placemark Investments’s Novartis NVS Stock Holding History

Placemark Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$15.5M	Buy	186,865 +572	+0.3%	+$47.4K	0.27%	83
2014 Q3	$15.7M	Buy	186,293 +6,049	+3%	+$489K	0.29%	73
2014 Q2	$14.6M	Buy	180,244 +17,814	+11%	+$1.4M	0.26%	79
2014 Q1	$12.4M	Sell	162,430 -226,955	-58%	-$16.5M	0.24%	87
2013 Q4	$28M	Buy	389,385 +43,814	+13%	+$3.05M	0.46%	33
2013 Q3	$23.7M	Buy	345,571 +16,653	+5%	+$1.1M	0.45%	38
2013 Q2	$20.8M	Buy	+328,918	New	+$21.4M	0.45%	44

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Placemark Investments's NVS Position: Q4 2014 in Review

Placemark Investments increased its Novartis (NVS) stake by 0.31% in Q4 2014, buying an estimated $47.4K and bringing the position to 186,865 shares worth $15.5M. The position accounts for 0.27% of the portfolio, ranked #83.

Placemark Investments first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $28M in Q4 2013. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Placemark Investments held 186,865 shares of Novartis worth $15.5M as of Q4 2014.
Placemark Investments bought 572 Novartis shares in Q4 2014, an estimated $47.4K.
Novartis made up 0.27% of Placemark Investments's portfolio in Q4 2014, its #83 holding.
Placemark Investments first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Novartis position peaked at $28M in Q4 2013.
918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.